Chargement en cours...

Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection

BACKGROUND: Fingolimod, a sphingosine-1-phosphate receptor modulator with well-described immunomodulatory properties involving peripheral immune cell trafficking, was the first oral agent approved for the treatment of relapsing remitting multiple sclerosis. Analogous immunomodulatory treatment optio...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Neuroinflammation
Auteurs principaux: Ambrosius, Björn, Pitarokoili, Kalliopi, Schrewe, Lisa, Pedreiturria, Xiomara, Motte, Jeremias, Gold, Ralf
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5406994/
https://ncbi.nlm.nih.gov/pubmed/28446186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-017-0864-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!